{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:21:28Z","timestamp":1768400488288,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["MAT2014-59134R"],"award-info":[{"award-number":["MAT2014-59134R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s11095-017-2319-8","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T18:03:51Z","timestamp":1515002631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders"],"prefix":"10.1007","volume":"35","author":[{"given":"Marcelle","family":"Silva-Abreu","sequence":"first","affiliation":[]},{"given":"Ana Cristina","family":"Calpena","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Espina","sequence":"additional","affiliation":[]},{"given":"Amelia M.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Alvaro","family":"Gimeno","sequence":"additional","affiliation":[]},{"given":"Mar\u00eda Antonia","family":"Egea","sequence":"additional","affiliation":[]},{"given":"Mar\u00eda Luisa","family":"Garc\u00eda","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"2319_CR1","first-page":"2279","volume":"15","author":"H Pan","year":"2009","unstructured":"Pan H, Chen J, Xu J, Chen M, Ma R. Antifibrotic effect by activation of peroxisome proliferator- activated receptor \u2013 \u03b3 in corneal fibroblasts. Mol Vis. 2009;15:2279\u201386.","journal-title":"Mol Vis"},{"key":"2319_CR2","doi-asserted-by":"publisher","unstructured":"Yamamoto A, Kakuta H, Miyachi H, Sugimoto Y. Involvement of the retinoid X receptor ligand in the anti-inflammatory effect induced by peroxisome proliferator-activated receptor agonist in vivo. PPAR Res. 2011;2011:1\u20138. https:\/\/doi.org\/10.1155\/2011\/840194","DOI":"10.1155\/2011\/840194"},{"key":"2319_CR3","doi-asserted-by":"crossref","unstructured":"Okunuki Y, Usui Y, Nakagawa H, Tajima K, Matsuda R, Ueda S, et al. Peroxisome proliferator-activated receptor-\u03b3 agonist pioglitazone suppresses experimental autoimmune uveitis. Exp Eye Res. 2013;116:291\u20137.","DOI":"10.1016\/j.exer.2013.09.017"},{"key":"2319_CR4","first-page":"2135","volume":"19","author":"M Uchiyama","year":"2013","unstructured":"Uchiyama M, Shimizu A, Masuda Y, Nagasaka S, Fukuda Y, Takahashi H. An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model. Mol Vis. 2013;19:2135\u201350.","journal-title":"Mol Vis"},{"issue":"1","key":"2319_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-5173(97)00083-5","volume":"153","author":"P Calvo","year":"1997","unstructured":"Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm. 1997;153(1):41\u201350.","journal-title":"Int J Pharm"},{"issue":"1","key":"2319_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.colsurfb.2009.03.028","volume":"72","author":"J Ara\u00fajo","year":"2009","unstructured":"Ara\u00fajo J, Vega E, Lopes C, Egea MA, Garcia ML, Souto EB. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B: Biointerfaces. 2009;72(1):48\u201356.","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"3","key":"2319_CR7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nano.2015.01.004","volume":"11","author":"HL Alvarado","year":"2015","unstructured":"Alvarado HL, Abrego G, Gardu\u00f1o-Ramirez ML, Clares B, Calpena AC, Garc\u00eda ML. Design and optimization of oleanolic\/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications. Nanomed Nanotech Biol Med. 2015;11(3):521\u201330.","journal-title":"Nanomed Nanotech Biol Med"},{"key":"2319_CR8","doi-asserted-by":"crossref","unstructured":"Parra A, Mallandrich M, Clares B, Egea MA, Espina M, Garcia ML, et al. Design and elaboration of freeze-dried PLGA nanoparticles for the transcorneal permeation of carprofen: Ocular anti-inflammatory applications. Colloids Surf B: Biointerfaces. 2015;136:935\u201343.","DOI":"10.1016\/j.colsurfb.2015.10.026"},{"key":"2319_CR9","doi-asserted-by":"crossref","unstructured":"Fangueiro JF, Calpena AC, Clares B, Andreani T, Egea MA, Veiga FJ, et al. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies. Int J Pharm. 2016;502(1\u20132):161\u20139.","DOI":"10.1016\/j.ijpharm.2016.02.039"},{"key":"2319_CR10","doi-asserted-by":"crossref","unstructured":"Ramos GR, Garcia ML, Espina M, Parra A, Calpena AC. Influence of freeze-drying and\u00a0\u03b3-irradiation in preclinical studies of flurbiprofen polymeric nanoparticles for ocular delivery using d-(+)-trehalose and polyethylene glycol. Int J Nanomedicine. 2016;11:4093\u2013106.","DOI":"10.2147\/IJN.S105606"},{"issue":"1","key":"2319_CR11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0928-0987(03)00178-7","volume":"20","author":"AM Campos De","year":"2003","unstructured":"De Campos AM, S\u00e1nchez A, Gref R, Calvo P, Alonso MJ. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci. 2003;20(1):73\u201381.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"2319_CR12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V. PLGA-based nanoparticles: An overview of biomedical applications. J Control Release. 2012;161(2):505\u201322.","journal-title":"J Control Release"},{"key":"2319_CR13","doi-asserted-by":"crossref","unstructured":"Ca\u00f1adas C, Alvarado H, Calpena AC, Silva AM, Souto EB, Garcia ML, et al. vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration. Int J Pharm. 2016;511(2):719\u201327.","DOI":"10.1016\/j.ijpharm.2016.07.055"},{"issue":"1","key":"2319_CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-5173(02)00548-3","volume":"250","author":"Y Xu","year":"2003","unstructured":"Xu Y, Effect DY. of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm. 2003;250(1):215\u201326.","journal-title":"Int J Pharm"},{"key":"2319_CR15","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-L\u00f3pez E, Egea MA, Cano A, Espina M, Calpena AC, Ettcheto M, et al. PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization. Colloids Surf B: Biointerfaces. 2016;145:241\u201350.","DOI":"10.1016\/j.colsurfb.2016.04.054"},{"issue":"1","key":"2319_CR16","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","volume":"55","author":"H Fessi","year":"1989","unstructured":"Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 1989;55(1):R1\u20134.","journal-title":"Int J Pharm"},{"issue":"5","key":"2319_CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jpha.2014.02.002","volume":"4","author":"N Satheeshkumar","year":"2014","unstructured":"Satheeshkumar N, Shantikumar S, Srinivas R. 2014. Pioglitazone: A review of analytical methods. J Pharm Anal. 2014;4(5):295\u2013302.","journal-title":"J Pharm Anal"},{"key":"2319_CR18","doi-asserted-by":"crossref","unstructured":"Clogston JD, Patri AK. Zeta Potential Measurement. In: McNeil SE, editor. Characterization of nanoparticles intended for drug delivery. Totowa: Humana Press; 2011. p. 63\u201370.","DOI":"10.1007\/978-1-60327-198-1_6"},{"key":"2319_CR19","doi-asserted-by":"crossref","unstructured":"Vega E, Gamisans F, Garc\u00eda ML, Chauvet A, Lacoulonche F, Egea MA. PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions. J Pharm Sci. 2008;97:5306\u201317.","DOI":"10.1002\/jps.21383"},{"key":"2319_CR20","doi-asserted-by":"crossref","unstructured":"Abrego G, Alvarado H, Souto EB, Guevara B, Bellowa LH, Parra A, et al. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration. Eur J Pharm Biopharm. 2015;95:261\u201370.","DOI":"10.1016\/j.ejpb.2015.01.026"},{"issue":"10","key":"2319_CR21","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/jps.24101","volume":"103","author":"G Abrego","year":"2014","unstructured":"Abrego G, Alvarado HL, Egea MA, Gonzalez-Mira E, Calpena AC, Garcia ML. Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen. J Pharm Sci. 2014;103(10):3153\u201364.","journal-title":"J Pharm Sci"},{"key":"2319_CR22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01117450","volume":"6","author":"K Yamaoka","year":"1978","unstructured":"Yamaoka K, Nakagawa T, Uno T. 1978. Application of Akaike\u2019s information Criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 1978;6:165\u201375.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"2","key":"2319_CR23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0278-6915(85)90030-4","volume":"23","author":"NP Luepke","year":"1985","unstructured":"Luepke NP. Hen\u2019s egg chorioallantoic membrane test for irritation potential. Food Chem Toxicol. 1985;23(2):287\u201391.","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"2319_CR24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3565(25)08751-8","volume":"82","author":"J Draize","year":"1944","unstructured":"Draize J, Woodard G, Calvery H. 1944. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82(3):377\u201390.","journal-title":"J Pharmacol Exp Ther"},{"key":"2319_CR25","first-page":"281","volume":"13","author":"JH Kay","year":"1962","unstructured":"Kay JH, Calandra JC. Interpretation of eye irritation tests. J Soc Cosmet Chem. 1962;13:281\u20139.","journal-title":"J Soc Cosmet Chem"},{"key":"2319_CR26","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.colsurfb.2014.10.047","volume":"123","author":"T Andreani","year":"2014","unstructured":"Andreani T, et al. Surface engineering of silica nanoparticles for oral insulin delivery: Characterization and cell toxicity studies. Colloids Surf B: Biointerfaces. 2014;123:916\u201323.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"2319_CR27","doi-asserted-by":"crossref","unstructured":"Vega E, Egea MA, Calpena AC, Espina M, Garc\u00eda ML. Role of hydroxypropyl-B-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery. Int J Nanomedicine. 2012;7:1357\u201371.","DOI":"10.2147\/IJN.S28481"},{"issue":"12","key":"2319_CR28","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","volume":"87","author":"MR Prausnitz","year":"1998","unstructured":"Prausnitz MR, Noonan JS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87(12):1479\u201388.","journal-title":"J Pharm Sci"},{"key":"2319_CR29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0168-3659(93)90097-O","volume":"25","author":"T Niwa","year":"1993","unstructured":"Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide\/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Control Release. 1993;25:89\u201398.","journal-title":"J Control Release"},{"key":"2319_CR30","doi-asserted-by":"publisher","unstructured":"Resende AP, Silva B, Braz BS, Nunes T, Gon\u00e7alves L, Delgado E. Ex vivo permeation of erythropoietin through porcine conjunctiva, cornea and sclera. Drug Deliv Transl Res. 2017;7(5):625\u201331. https:\/\/doi.org\/10.1007\/s13346-017-0399-y","DOI":"10.1007\/s13346-017-0399-y"},{"key":"2319_CR31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-4899-7630-7_14","volume-title":"Structure-Based Mechanics of Tissues and Organs [Internet]","author":"TD Nguyen","year":"2016","unstructured":"Nguyen TD. Biomechanics of the Cornea and Sclera. In: Kassab GS, Sacks MS, editors. Structure-Based Mechanics of Tissues and Organs [Internet]. Boston: Springer US; 2016. p. 285\u2013315."},{"issue":"6","key":"2319_CR32","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.nano.2011.10.015","volume":"8","author":"J Ara\u00fajo","year":"2012","unstructured":"Ara\u00fajo J, Garcia ML, Mallandrich M, Souto EB, Calpena AC. Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): In vitro and ex vivo studies. Nanomed Nanotech Biol Med. 2012;8(6):1034\u201341.","journal-title":"Nanomed Nanotech Biol Med"},{"key":"2319_CR33","doi-asserted-by":"crossref","unstructured":"Wen HE, Hao J, Li SK. Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab. J Pharm Sci. 2013;102(3):892\u2013903.","DOI":"10.1002\/jps.23387"},{"issue":"7","key":"2319_CR34","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.bbadis.2014.03.015","volume":"1842","author":"W Shen","year":"2014","unstructured":"Shen W, Gao Y, Lu B, Zhang Q, Hu Y, Chen Y. Negatively regulating TLR4\/NF-kB signaling via PPAR in endotoxin-induced uveitis. Biochim Biophys Acta Mol Basis Dis. 2014;1842(7):1109\u201320.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"2319_CR35","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/jps.2600721108","volume":"72","author":"DS Ronald","year":"1983","unstructured":"Ronald DS, Huang HS. Corneal Penetration Behavior of \u03b2-Blocking Agents I: Physicochemical Factors. J Pharm Sci. 1983;72(11):1266\u201372.","journal-title":"J Pharm Sci"},{"key":"2319_CR36","first-page":"609","volume":"10","author":"A Vasconcelos","year":"2015","unstructured":"Vasconcelos A, Vega E, P\u00e9rez Y, G\u00f3mara MJ, Garc\u00eda ML, Haro I. Conjugation of cell-penetrating peptides with poly(Lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery. Int J Nanomedicine. 2015;10:609\u201331.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"2319_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1099-1263(199905\/06)19:3<163::AID-JAT561>3.0.CO;2-H","volume":"19","author":"B Arechabala","year":"1999","unstructured":"Arechabala B, Coiffard C, Rivalland P, Coiffard LJM. De Roeck-Holtzhauer Y. Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release. J Appl Toxicol. 1999;19(3):163\u20135.","journal-title":"J Appl Toxicol"},{"key":"2319_CR38","doi-asserted-by":"crossref","unstructured":"Jiang Y, Thakran S, Bheemreddy R, Ye EA, He H, Walker RJ, et al. Pioglitazone normalizes insulin signaling in the diabetic rat retina through reduction in tumor necrosis factor and suppressor of cytokine signaling 3*. J Biol Chem. 2014;289(38):26395\u2013405.","DOI":"10.1074\/jbc.M114.583880"},{"key":"2319_CR39","doi-asserted-by":"crossref","unstructured":"Murata T, Hata Y, Ishibashi T, Kim S, Hsueh WA, Law RE, et al. Response of experimental retinal neovascularization to thiazolidinediones. Arch Ophthalmol. 2001;119(5):709\u201317.","DOI":"10.1001\/archopht.119.5.709"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-017-2319-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-017-2319-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-017-2319-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T10:29:45Z","timestamp":1751192985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-017-2319-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["2319"],"URL":"https:\/\/doi.org\/10.1007\/s11095-017-2319-8","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]},"article-number":"11"}}